1. Sulzer D, Alcalay RN, Garretti F, et al. T cells from patients with Parkinson's disease recognize alpha-synuclein peptides. Nature. 2017;546(7660):656-661.
2. Lindestam Arlehamn CS, Dhanwani R, Pham J, et al. alpha-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease. Nature communications. 2020;11(1):1875.
3. Wissemann WT, Hill-Burns EM, Zabetian CP, et al. Association of Parkinson disease with structural and regulatory variants in the HLA region. Am J Hum Genet. 2013;93(5):984-993.
4. Lodygin D, Hermann M, Schweingruber N, et al. beta-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566(7745):503-508.
5. Kordower JH, Olanow CW, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain. 2013;136(Pt 8):2419-2431.
6. Matheoud D, Cannon T, Voisin A, et al. Intestinal infection triggers Parkinson's disease-like symptoms in Pink1(-/-) mice. Nature. 2019;571(7766):565-569.
7. Lindestam Arlehamn CS, Pham J, Alcalay RN, et al. Widespread Tau-Specific CD4 T Cell Reactivity in the General Population. J Immunol. 2019.
8. Singhania A, Pham J, Dhanwani R, et al. The TCR repertoire of alpha-synuclein-specific T cells in Parkinson's disease is surprisingly diverse. Scientific reports. 2021;11(1):302.
9. Lindestam Arlehamn CS, Garretti F, Sulzer D, Sette A. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases. Curr Opin Immunol. 2019;59:115-120.
10. Peter I, Dubinsky M, Bressman S, et al. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease. JAMA Neurol. 2018;75(8):939-946.